ESCRS - Mayo Clinic researchers demonstrate value of second opinions

Mayo Clinic researchers demonstrate value of second opinions

88 percent of patients go home with a new or refined diagnosis

Mayo Clinic researchers demonstrate value of second opinions
Colin Kerr
Colin Kerr
Published: Tuesday, April 4, 2017
Second Opinion?
In a new study, the Mayo Clinic has reported that many patients come to their clinic for a second opinion or diagnosis confirmation before treatment for a complex condition. As many as 88 percent of those patients go home with a new or refined diagnosis. Conversely, only 12 percent receive confirmation that the original diagnosis was complete and correct. These findings were published online in the Journal of Evaluation in Clinical Practice. The research team was led by James Naessens, Sc.D., a health care policy researcher at Mayo Clinic.
Tags: patients
Latest Articles
Diamonds in the Rough

The push for inclusivity in ophthalmology.

Read more...

Making Female Leadership More than a Moment

A remarkable global confluence of women in key positions.

Read more...

ESCRS Talks Technology at AAO

Europe adopts technological advances, US still waiting for lenses and lasers.

Read more...

Sorting Out Simultaneous Vision IOLs

The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.

Read more...

Big Advantages to Small-Aperture IOLs

Small-aperture IOLs offer superior image quality with increased range of focus.

Read more...

Prioritising Self-Care

Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.

Read more...

Valuing Clinical Trial Design

How inclusivity and diversity can enhance scientific accuracy in research.

Read more...

Knowing Iris Repair: Using Iridodiathermy in Iris Surgery

Prepare for decentred pupils and uneven irides in multiple situations.

Read more...

Neuroprotectant Treatment for MacTel Type 2

Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.

Read more...

Supplement: Maximizing Visual Quality in Refractive Surgery Through Enhanced Precision and Safety

Read more...